Protein Assays Market Trends Driving Innovation in Biomedical Research

The global protein assays market size was valued at USD 2.03 billion in 2024 and is projected to grow from USD 2.26 billion in 2025 to USD 5.35 billion by 2033, registering a CAGR of 11.34% during the forecast period (2025–2033).

Protein assays are analytical methods used to determine the concentration or quantity of proteins in biological samples. These assays play a critical role in drug discovery, disease diagnosis, biotechnology research, and clinical testing. Increasing incidences of chronic and infectious diseases, along with growing investments in pharmaceutical and biological research, are driving the expansion of the global protein assays market.

Rising Prevalence of Chronic and Infectious Diseases Drives Market Growth

The increasing burden of chronic and infectious diseases worldwide is a major factor accelerating the demand for protein assays. Protein-based research approaches are widely utilized to study diseases such as cancer, HIV/AIDS, influenza, tuberculosis, and neurological disorders.

According to global health statistics, non-communicable diseases account for millions of deaths annually, while cancer cases continue to rise significantly worldwide. Protein assays help researchers identify biomarkers, study disease mechanisms, and support the development of targeted therapies, thereby increasing their adoption across pharmaceutical and research institutions.

Growing Pharmaceutical R&D Investments Fuel Market Expansion

The rapid increase in pharmaceutical and biotechnology research expenditure is significantly contributing to the growth of the protein assays market. Pharmaceutical companies and research organizations are heavily investing in the development of innovative therapies and precision medicine technologies.

The growing focus on genomics, proteomics, and synthetic biology is further creating demand for advanced protein analysis tools and reagents. Increasing government support and research funding across developed and emerging economies are expected to strengthen market growth over the coming years.

Technological Advancements Create New Growth Opportunities

Technological innovations in protein assay techniques are opening new opportunities for market participants. Companies are introducing advanced multiplex protein assays, next-generation sequencing-compatible assays, and automated immunoassay platforms to improve analytical accuracy and workflow efficiency.

Recent advancements in spatial biology, single-cell protein analysis, and immuno-oncology applications are expected to revolutionize disease diagnostics and drug development processes. The growing adoption of automated and high-throughput protein assay systems is further supporting market expansion.

High Equipment Costs Remain a Key Challenge

Despite strong growth prospects, the high cost associated with protein assay equipment and consumables remains a significant restraint for market growth. Advanced multiplex assay systems, maintenance expenses, and costly reagents limit adoption, particularly in low-income and resource-constrained healthcare settings.

Additionally, the continuous need for machine upgrades, spare parts, and consumables increases operational expenses for laboratories and healthcare facilities.

North America Dominates the Global Protein Assays Market

North America accounted for the largest market share of 35.04% in 2024 and is expected to maintain its leading position during the forecast period. The presence of major pharmaceutical companies, advanced healthcare infrastructure, and increasing investments in drug discovery activities are key factors driving regional growth.

The United States remains a major contributor due to strong research funding, rising chronic disease prevalence, and increasing demand for precision diagnostics. The region also benefits from extensive adoption of advanced laboratory technologies and strong biotechnology research capabilities.

Europe Emerges as a Fast-Growing Regional Market

Europe is anticipated to witness substantial growth driven by rising incidences of infectious diseases, expanding pharmaceutical research activities, and increasing investments in genomics and proteomics research.

Countries such as Germany, the UK, and France are actively investing in diagnostics and biomedical innovation, which is accelerating the adoption of protein assay technologies across research laboratories and healthcare facilities.

Asia-Pacific Presents Significant Growth Opportunities

The Asia-Pacific protein assays market is expected to grow rapidly due to increasing healthcare expenditure, expanding pharmaceutical manufacturing, and rising cancer incidence across countries such as China, India, and Japan.

Growing collaborations between biotechnology firms and research organizations, coupled with increasing adoption of advanced diagnostic technologies, are supporting regional market development. Government initiatives promoting healthcare innovation and research activities are further boosting market growth.

Reagents Segment Holds Largest Market Share

Based on product type, the reagents segment dominates the global protein assays market and is projected to grow at a CAGR of 12.34% during the forecast period. The increasing launch of innovative reagents for disease detection and protein analysis is driving segment expansion.

Protein assay reagents are widely used across research laboratories, pharmaceutical companies, and clinical diagnostic centers due to their critical role in protein quantification and biomarker analysis.

Drug Discovery and Development Segment Leads Applications

The drug discovery and development segment represents the largest application area for protein assays. Protein analysis plays a central role in identifying therapeutic targets, studying drug mechanisms, and evaluating treatment efficacy.

The increasing number of global drug discovery projects and growing demand for personalized medicine are expected to further strengthen the adoption of protein assay technologies across pharmaceutical and biotechnology industries.

Key Companies Operating in the Protein Assays Market

Key players operating in the global protein assays market include:

• Merck KGaA
• Promega Corporation
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Abcam Plc
• Cell Signaling Technology
• Qiagen
• F. Hoffmann-La Roche
• Danaher Corporation
• PerkinElmer

Recent Industry Developments

May 2023

10x Genomics announced the commercial launch of the Visium CytAssist Gene and Protein Expression product, expanding spatial biology analysis capabilities.

August 2023

BD commercially released the BD AbSeq assay designed for high-throughput single-cell protein expression analysis using sequencing technology.

Conclusion

The global protein assays market is poised for substantial growth due to rising chronic disease prevalence, increasing pharmaceutical R&D investments, and continuous technological advancements in protein analysis techniques. Growing demand for precision medicine, biomarker discovery, and advanced diagnostic tools is expected to create significant opportunities for industry participants over the forecast period.

Read Full protein assays market Report -https://straitsresearch.com/report/protein-assays-market

About Us:

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.